BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29637743)

  • 1. Specific issues concerning the management of patients on the waiting list and after liver transplantation.
    Burra P; Giannini EG; Caraceni P; Ginanni Corradini S; Rendina M; Volpes R; Toniutto P
    Liver Int; 2018 Aug; 38(8):1338-1362. PubMed ID: 29637743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common issues in the management of patients in the waiting list and after liver transplantation.
    Burra P; Belli LS; Ginanni Corradini S; Volpes R; Marzioni M; Giannini E; Toniutto P
    Dig Liver Dis; 2017 Mar; 49(3):241-253. PubMed ID: 28096056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [V Consensus Meeting of the Spanish Society for Liver Transplant on high-risk recipients, immunosupression scenarios and management of hepatocarcinoma on the transplant waiting list].
    Pardo F; Pons JA; BriceƱo J;
    Gastroenterol Hepatol; 2015 Dec; 38(10):600-18. PubMed ID: 26404045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skills and requirements of a transplant hepatologist: board certification of the Italian Association for the Study of the Liver (AISF).
    Burra P; Belli L; Fagiuoli S; Angelico M; Costa AN; Caraceni P; Toniutto P
    Dig Liver Dis; 2013 Dec; 45(12):992-4. PubMed ID: 23816698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
    Vitale A; Volk ML; De Feo TM; Burra P; Frigo AC; Ramirez Morales R; De Carlis L; Belli L; Colledan M; Fagiuoli S; Rossi G; Andorno E; Baccarani U; Regalia E; Vivarelli M; Donataccio M; Cillo U;
    J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Candidates.
    Terrault NA; McCaughan GW; Curry MP; Gane E; Fagiuoli S; Fung JYY; Agarwal K; Lilly L; Strasser SI; Brown KA; Gadano A; Kwo PY; Burra P; Samuel D; Charlton M; Pessoa MG; Berenguer M
    Transplantation; 2017 May; 101(5):945-955. PubMed ID: 28437387
    [No Abstract]   [Full Text] [Related]  

  • 7. Liver transplantation in Spain.
    de la Rosa G; Fondevila C; Navasa M
    Liver Transpl; 2016 Sep; 22(9):1259-64. PubMed ID: 27197947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report.
    Clavien PA; Lesurtel M; Bossuyt PM; Gores GJ; Langer B; Perrier A;
    Lancet Oncol; 2012 Jan; 13(1):e11-22. PubMed ID: 22047762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donation after cardiac death in the hepatocellular carcinoma patient: Same indication?
    Vining CC; Ecker BL; Abt PL; Olthoff KM
    Liver Transpl; 2017 Oct; 23(S1):S27-S33. PubMed ID: 28846212
    [No Abstract]   [Full Text] [Related]  

  • 10. Liver transplantation in Germany.
    Tacke F; Kroy DC; Barreiros AP; Neumann UP
    Liver Transpl; 2016 Aug; 22(8):1136-42. PubMed ID: 27082951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excess mortality on the liver transplant waiting list: unintended policy consequences and Model for End-Stage Liver Disease (MELD) inflation.
    Northup PG; Intagliata NM; Shah NL; Pelletier SJ; Berg CL; Argo CK
    Hepatology; 2015 Jan; 61(1):285-91. PubMed ID: 24995689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Top ten facts you need to know: about liver transplantation.
    Butt FK; Earl TM; Anderson CD
    J Miss State Med Assoc; 2014 Jul; 55(7):212-5. PubMed ID: 25252424
    [No Abstract]   [Full Text] [Related]  

  • 13. Invited commentary.
    Freeman RB
    J Am Coll Surg; 2015 Jun; 220(6):1007-9. PubMed ID: 25998078
    [No Abstract]   [Full Text] [Related]  

  • 14. Practice of adult liver transplantation in Italy. Recommendations of the Italian Association for the Study of the Liver (A.I.S.F.).
    Angelico M; Gridelli B; Strazzabosco M;
    Dig Liver Dis; 2005 Jul; 37(7):461-7. PubMed ID: 15893508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intention to treat outcome of T1 hepatocellular carcinoma with the "wait and not ablate" approach until meeting T2 criteria for liver transplant listing.
    Mehta N; Sarkar M; Dodge JL; Fidelman N; Roberts JP; Yao FY
    Liver Transpl; 2016 Feb; 22(2):178-87. PubMed ID: 26479422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver transplantation for hepatocellular carcinoma.
    Rude MK; Crippin JS
    Curr Gastroenterol Rep; 2015 Mar; 17(3):11. PubMed ID: 25740250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of a dropout assessment model of candidates with/without hepatocellular carcinoma on a common liver transplant waiting list.
    Toso C; Majno P; Berney T; Morel P; Mentha G; Combescure C
    Transpl Int; 2014 Jul; 27(7):686-95. PubMed ID: 24649861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients With Hepatocellular Carcinoma Have Highest Rates of Wait-listing for Liver Transplantation Among Patients With End-Stage Liver Disease.
    Goldberg D; French B; Newcomb C; Liu Q; Sahota G; Wallace AE; Forde KA; Lewis JD; Halpern SD
    Clin Gastroenterol Hepatol; 2016 Nov; 14(11):1638-1646.e2. PubMed ID: 27374003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Model for end-stage liver disease exceptions: proceed with caution.
    Washburn K
    Liver Transpl; 2011 Oct; 17(10):1123-4. PubMed ID: 21837739
    [No Abstract]   [Full Text] [Related]  

  • 20. The race to liver transplantation: a comparison of patients with and without hepatocellular carcinoma from listing to post-transplantation.
    Patel MS; Kohn R; Kratz JR; Shah JA; Markmann JF; Vagefi PA
    J Am Coll Surg; 2015 Jun; 220(6):1001-7. PubMed ID: 25868408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.